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We report a case of atypical lymphocytic lobular panniculitis  (ALLP) characterized 
by recurrent subcutaneous nodules with similar molecular and phenotypic profile 
of cutaneous T-cell lymphoma. A twenty-one year old female presented with a 
six-year history of recurrent erythema nodosum on the lower extremities. The 
histopathology revealed a lobular panniculitis composed of histiocytes and slightly 
atypical, predominately CD3 positive lymphocytes consistent with the diagnosis of 
ALLP. ALLP represents a spectrum of cutaneous lymphoid dyscrasia characterized 
by recalcitrant and insidious clinical course and atypical lymphocytic infiltration that 
do not fulfill the diagnostic criteria of lymphoma. Due to its possible association 
with subcutaneous panniculitis-like T-cell lymphoma and potential for malignant 
transformation, recognizing ALLP as a distinct entity is important in understanding 
the clinical and management spectrum of lymphocytic lobular panniculitis.
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TREATMENT
•  Goal of treatment is to halt the progression to lymphoma 
•  Corticosteroids and nonsteriodal anti-inflammatories for 
pain
•  Oral retinoid therapy for persistent lesions
•  Case series by Magro et al. reported treatments with 
dapsone, hydroxychloroquine, interferon, and anti-CD52 
monoclonal antibody alemtuzumab, which is currently 
approved for the treatment of chronic lymphocytic leukemia 
PROGNOSIS
•  Exact prognosis remains unknown 
•  Reported cases of ALLP follow an indolent course and no 
reported cases of ALLP progressing to STCL
•  However, few cases of STCL where history of waxing and 
waning patterns have been observed
•  Persistent identical T-cell clone at different biopsy sites 
over time has been demonstrated in ALLP 
•  Therefore, ALLP may represent a preneoplastic phase of 
STCL and close monitoring and follow up is warranted
•  Recommend repeat biopsy and laboratory studies 
with changes in clinical symptoms, lesion morphology, 
distribution, progression, and therapy responsiveness
HPI:-one year old female with a six-year history of recurrent “erythema nodosum”. 
Reports painful and pruritic lesions on the lower extremities that usually resolve 
spontaneously within one month and recurs about one to two episodes per year. No 
prodromal symptoms.
ROS: Mild intermittent shortness of breath and joint pain
PMHx/Family Hx: Non-contributory
PE: Afebrile, alert female without acute distress. Multiple indurated, erythematous, 
subcutaneous, tender nodules and plaques located on the forearms and lower 
extremities. No lower extremity edema. 
Laboratory Evaluation: Mildly elevated erythrocyte sedimentation rate of 33 
(0-20mm/hr). Complete blood count, rheumatoid factor, antinuclear antibody, and 
streptolysin O antibody were all negative and within normal limits. 
Skin biopsy of nodule on the right medial calf:
Histopathology- mild spongiosis and focal haphazard migration of lymphocytes into 
the epidermis, patchy mild perivascular and periappendageal lymphocytic infiltrate 
with rare eosinophils extending into the deep dermis, mildly increased dermal 
mucin seen by Alcian Blue stain, and a subcutaneous lobular inflammatory infiltrate 
composed of histiocytes and small to intermediate size, mildly atypical lymphocytes 
(figure 1). No erythrocyte phagocytosis. 
Phenotypic studies of inflammatory infiltrate using immunohistochemical stains- 
co-expression of predominantly CD3 and CD2 positive T cells. CD5 and CD7 cells 
expressed without prominent loss of antigenicity. No prominent CD30 positive or 
CD56 positive cells. CD68 positive cells consistent with histiocytes were seen. 
PCR-T cell receptor gamma chain gene - rearrangement of inflammatory infiltrate- 
polyclonal.
Diagnosis: Atypical lymphocytic lobular panniculitis
Treatment: Systemic corticosteroids, indomethacin, and naproxen for pain 
control. However, the lesions recurred and most recent episode involved buttocks 
and abdomen (figure 2). 
Case Presentation:
Discussion:
ALLP as described by Magro et al. represents a spectrum of disorders with 
recalcitrant and insidious clinical course and atypical lymphocytic infiltration. 
Other disorders in this spectrum include alopecia mucinosa, pityriasis lichenoides 
chronica, large plaque parapsoriasis, idiopathic follicular erythroderma, mucinosis, 
pigmented purpuric dermatoses, and atypical hypopigmented interface variant 
dermatoses.
Some authors suggest that ALLP is a concomitant presentation or overlap of STCL 
and LEP. Willemze et al. reported that 19% of STCL patients had an associated 
autoimmune disorder with lupus erythematosus (LE) being the most common.  
There are reported cases where diagnosis of earlier LEP has been changed to 
STCL.  Pincus et al observed one STCL patient with a positive DIF test without 
histopathologic feature of LE. Monoclonal pattern has been demonstrated in 70 
to 75% of ALLP patients. Therefore, the use of TCR gene rearrangement study in 
distinguishing the ALLP from malignant process should be made with caution. Initial 
screening should include rheumatologic 
work up including complete blood count, 
rheumatoid factor, antinuclear antibody, 
and erythrocyte sedimentation. Similarly, 
LEP patients should also be followed 
closely due to its close association with 
STCL. Perhaps ALLP may represent 
a continuum of inflammatory disarray 
from chronic antigenic stimulation. This 
stimulation then can prime the initial 
benign process to possible clonal selection 
and proliferation leading to malignant 
transformation (figure 3). 
Figure 3.  Proposed schematic representation 
of lymphocytic lobular panniculitis as a 
spectrum of inflammatory disarray from 
chronic antigenic stimulation.
Figure 1.  (A) 20X magnification- 
Epidermal and dermal 
involvement are minimal in 
ALLP. Epidermis may show 
subtle lymphocytic exocytosis. 
(B) 40X magnification-
Lymphoid infiltrate of small to 
medium sized cells within the 
subcutaneous tissue in lobular 
pattern. 
Figure 2.  Indurated, 
erythematous, subcutaneous, 
tender nodules on the abdomen.
Table 1.  Comparison of clinical features of ALLP, STCL, and LEP
M = male, F = female, LE = lupus erythematosus












Septal fibrosis and 
prominent mucin
B-cell follicles, plasma cells
Immunophenotypic ↓CD5, CD7 cells ↓ ↓CD5, CD7 cells
Predominant cytotoxic CD8 cells
T & B-cells
DIF: IgG and C3 deposition at 
BMZ
Molecular Monoclonal Monoclonal/Polyclonal Polyclonal
Table 2.  Comparison of histopathologic features of ALLP, STCL, and LEP
DIF - Direct immunofluorescence, BMZ: Basement membrane zone
DIFFERENTIAL DIAGNOSIS
•  Subcutaneous panniculitis-like T cell lymphoma (STCL)
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